| Participants exposed to radioiodine (Group I) (n = 40) | Participants exposed to X-ray (Group II) (n = 40) | Control group (Group III) (n = 40) | p |
---|---|---|---|---|
Age (years) | ||||
 Min. – Max. | 24.0–57.0 | 22.0–51.0 | 22.0–51.0 | 0.291 |
 Mean ± SD. | 33.91 ± 10.30 | 31.16 ± 7.92 | 30.59 ± 7.12 | |
Sex: n (%) | ||||
 Female | 18 (45%) | 14 (35%) | 16 (40%) | 0.321 |
 Male | 22 (55%) | 26 (65%) | 24 (60%) | |
Working period (years) | ||||
 Min. – Max. | 2–20 | 1–38 | – | |
 Mean ± SD. | 7.50 ± 5.46 | 14.83 ± 10.91 | ||
Annual effective dose (mSv) | ||||
 Min. – Max. | 0.44–2.89 | 0.5–3.6 | – | |
 Mean ± SD. | 1.22 ± 0.88 | 1.53 ± 0.91 |